Report
Payer coverage trends of anti-obesity medications on commercial formularies
-
Michelle Friedman
-
Shaila Yoshida
Dive into the evolving landscape of payer coverage for anti-obesity medications (AOMs) with this insightful report. Based on proprietary survey data from 48 formulary decision-makers representing 253 million lives, the report explores current and anticipated coverage trends for AOMs like Wegovy® and Zepbound®, utilization management strategies, and the challenges payers face in balancing budget impacts with member health outcomes.
Key highlights:
- Current commercial insurance coverage and utilization management tools for AOMs
- Employer rider policies and anticipated shift to traditional formularies
- Challenges in managing AOM costs, long-term efficacy data, and member adherence
- Opportunities to improve access and outcomes with real-world evidence
Discover how payer decision-making is shaping the commercial AOM landscape and gain insights into the evolving dynamics of coverage and management.
Download the report now
Pardot Form
Connect with our team
Our commitment to helping clients achieve market access plays a crucial role in patients’ access to affordable, diverse, and effective therapies so they can achieve their best potential health outcomes. Connect with our team of experts to discover how we can help support your goals.
